Asian Pacific Journal of Cancer Prevention

Asian Pacific Journal of Cancer Prevention (아시아태평양암예방학회)
권호 표지
DOI QR코드

DOI QR Code

Quality of Life and Radiotherapy Complications of Chinese Nasopharyngeal Carcinoma Patients at Different 3DCRT Stages

  • Gu, Mo-Fa (Department of Radiation Oncology, Cancer Centre, Sun Yat-sen University) ;
  • Su, Yong (Department of Radiation Oncology, Cancer Centre, Sun Yat-sen University) ;
  • Chen, Xin-Lin (Department of Preventive Medicine and Medical Statistics, College of Fundamental Medical Science) ;
  • He, Wei-Ling (Department of Gastrointestinal and Pancreatic Surgery, the First Affiliated Hospital, Sun Yat-sen University) ;
  • He, Zhen-Yu (Department of Radiation Oncology, Cancer Centre, Sun Yat-sen University) ;
  • Li, Jian-Jun (Department of Radiation Oncology, Cancer Centre, Sun Yat-sen University) ;
  • Chen, Miao-Qiu (Office of the President, Guangzhou University of Chinese Medicine) ;
  • Mo, Chuan-Wei (Department of Preventive Medicine and Medical Statistics, College of Fundamental Medical Science) ;
  • Xu, Qian (Department of Preventive Medicine and Medical Statistics, College of Fundamental Medical Science) ;
  • Diao, Yuan-Ming (Department of Preventive Medicine and Medical Statistics, College of Fundamental Medical Science)
  • Published : 2012.01.31
Download PDF
⟨ Previous Next ⟩

Abstract

Purpose: the study aimed to compare the quality of life (QOL) and radiotherapy complications among Chinese nasopharyngeal carcinoma (NPC) patients at different 3-dimensional conformal radiotherapy (3DCRT) stages adjusting for other variables. Methods: 511 NPC patients at different 3DCRT stages were enrolled. They were interviewed regarding SF-36, complications and socio-demographic variables and cancer- or treatment-related variables. Analysis of covariance (ANCOVA) based on SF-36, complications scores as dependent variables, 3DCRT stages as independent variables, and other variables as covariate were established. Results: The influencing factors of PCS included 3DCRT stages and age group. The influencing factors of MCS included 3DCRT stages and income. Most QOL scores of NPC patients were significantly associated with 3DCRT stage, after accounting for other variables. QOL scores of the patients receiving 3DCRT were the lowest, QOL scores of people after 3DCRT gradually increased. PCS scores of people greater than 5 years after 3DCRT was improved to or even better than the level before 3DCRT. The complications with significantly different scores of patients at different 3DCRT status included xerostomia, throat ache, hypogeusia, caries, hearing loss, snuffles. Conclusions: Clinicians should pay more attention to older NPC patients and patients with lower income. When patients receive 3DCRT, measures should be taken to reduce radiation injury to improve the patients' QOL.

Keywords

References

  1. Chen YP, Tsang NM, Tseng CK, et al (2000). Causes of interruption of radiotherapy in nasopharyngeal carcinoma patients in Taiwan. Jpn J Clin Oncol, 30, 230-4. https://doi.org/10.1093/jjco/hyd059
  2. Demiral AN, Sen M, Demiral Y, et al (2008). The effect of socioeconomic factors on quality of life after treatment in patients with head and neck cancer. Int J Radiat Oncol Biol Phys, 70, 23-7. https://doi.org/10.1016/j.ijrobp.2007.05.056
  3. Fang FM, Chien CY, Tsai WL, et al (2008). Quality of life and survival outcome for patients with nasopharyngeal carcinoma receiving three-dimensional conformal radiotherapy vs. intensity-modulated radiotherapy-a longitudinal study. Int J Radiat Oncol Biol Phys, 72, 356-64. https://doi.org/10.1016/j.ijrobp.2007.12.054
  4. Fang FM, Chiu HC, Kuo WR, et al (2002). Health-related quality of life for nasopharyngeal carcinoma patients with cancer-free survival after treatment. Int J Radiat Oncol Biol Phys, 53, 959-68. https://doi.org/10.1016/S0360-3016(02)02838-9
  5. Hsiung CY, Yorke ED, Chui CS, et al (2002). Intensitymodulated radiotherapy versus conventional threedimensional conformal radiotherapy for boost or salvage treatment of nasopharyngeal carcinoma. Int J Radiat Oncol Biol Phys, 53, 638-47. https://doi.org/10.1016/S0360-3016(02)02760-8
  6. Huang HY, Wilkie DJ, Schubert MM, et al (2000). Symptom profile of nasopharyngeal cancer patients during radiation therapy. Cancer Practice, 8, 274-81. https://doi.org/10.1046/j.1523-5394.2000.86007.x
  7. Jensen SB, Pedersen AML, Vissink A, et al (2010). A systematic review of salivary gland hypofunction and xerostomia induced by cancer therapies: prevalence, severity and impact on quality of life. Support Care Cancer, 18, 1039-60. https://doi.org/10.1007/s00520-010-0827-8
  8. McMillan AS, Pow EH, Kwong DL, et al (2006). Preservation of quality of life after intensity-modulated radiotherapy for early-stage nasopharyngeal carcinoma: results of a prospective longitudinal study. Head Neck, 28, 712-22. https://doi.org/10.1002/hed.20378
  9. McMillan AS, Pow EH, Leung WK, et al (2004). Oral healthrelated quality of life in southern Chinese following radiotherapy for nasopharyngeal carcinoma. J Oral Rehabil, 31, 600-8. https://doi.org/10.1111/j.1365-2842.2004.01383.x
  10. Oates JE, Clark JR, Read J, et al (2007). Prospective evaluation of quality of life and nutrition before and after treatment for nasopharyngeal carcinoma. Arch Otolaryngol Head Neck Surg, 133, 533-40. https://doi.org/10.1001/archotol.133.6.533
  11. Ozaras G, Ozyurda F (2010). Quality of life and influencing factors in patients with a gynaecologic cancer diagnosis at gazi university, Turkey. Asian Pac J Cancer Prev, 11, 1403-1408.
  12. Palazzi M, Guzzo M, Tomatis S, et al (2004). Improved outcome of nasopharyngeal carcinoma treated with conventional radiotherapy. International Journal of Radiation Oncology* Biology* Physics, 60, 1451-8. https://doi.org/10.1016/j.ijrobp.2004.05.059
  13. Pow EH, Kwong DL, McMillan AS, et al (2006). Xerostomia and quality of life after intensity-modulated radiotherapy vs. conventional radiotherapy for early-stage nasopharyngeal carcinoma: initial report on a randomized controlled clinical trial. Int J Radiat Oncol Biol Phys, 66, 981-91. https://doi.org/10.1016/j.ijrobp.2006.06.013
  14. Pow EHN, McMillan AS, Leung WK, et al (2003). Salivary gland function and xerostomia in southern Chinese following radiotherapy for nasopharyngeal carcinoma. Clin Oral Investig, 7, 230-4. https://doi.org/10.1007/s00784-003-0215-6
  15. Sumitsawan Y, Chaiyasate S, Chitapanarux I, et al (2009). Late complications of radiotherapy for nasopharyngeal carcinoma. Auris Nasus Larynx, 36, 205-9. https://doi.org/10.1016/j.anl.2008.04.006
  16. Teo PM, Ma BB, Chan AT (2004). Radiotherapy for nasopharyngeal carcinoma--transition from two-dimensional to three-dimensional methods. Radiother Oncol, 73, 163-72. https://doi.org/10.1016/j.radonc.2004.06.005
  17. Tribius S, Bergelt C (2011). Intensity-modulated radiotherapy versus conventional and 3D conformal radiotherapy in patients with head and neck cancer: Is there a worthwhile quality of life gain? Cancer Treat Rev, 37, 511-9. https://doi.org/10.1016/j.ctrv.2011.01.004
  18. Ware JE, Jr Sherbourne CD (1992). The MOS 36-item shortform health survey (SF-36). I. Conceptual framework and item selection. Med Care, 30, 473-83. https://doi.org/10.1097/00005650-199206000-00002
  19. Wu VW, Ying MT, Kwong DL (2011). Evaluation of radiationinduced changes to parotid glands following conventional radiotherapy in patients with nasopharygneal carcinoma. Br J Radiol, 84, 843-9. https://doi.org/10.1259/bjr/55873561
  20. Wu Y, Hu WH, Xia YF, et al (2005). Quality of life of 192 disease-freely survival nasopharyngeal carcinoma patients after radiotherapy. Ai Zheng, 24, 1376-83.
  21. Wu Y, Hu WH, Xia YF, et al (2007). Quality of life of nasopharyngeal carcinoma survivors in Mainland China. Qual Life Res, 16, 65-74. https://doi.org/10.1007/s11136-006-9113-0
  22. Yeh SA, Tang Y, Lui CC, et al (2005). Treatment outcomes and late complications of 849 patients with nasopharyngeal carcinoma treated with radiotherapy alone. Int J Radiat Oncol Biol Phys, 62, 672-9. https://doi.org/10.1016/j.ijrobp.2004.11.002

Cited by

  1. Development and validation of quality of life scale of nasopharyngeal carcinoma patients: the QOL-NPC (version 2) vol.14, pp.1, 2016, https://doi.org/10.1186/s12955-016-0480-0